No Data
No Data
9 Out of 14 Healthcare Companies Beat Profit Estimates This Week- Earnings Scorecard
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years
Pharma CEOs Set to Meet With Trump at White House - Report
AstraZeneca Reports Positive Results for Imfinzi MIBC Regimen
AstraZeneca's IMFINZI Perioperative Regimen Improved Event-Free Survival And Overall Survival Across Muscle-Invasive Bladder Cancer Patients Regardless Of Complete Pathology Response Status In Post-Hoc Exploratory Analysis Of Niagara Phase III Trial
CRISPR Upped to Outperform by Evercore on Upcoming Data